What You Need To Know
Jersey Shore University Medical Center recently introduced the high-intensity focused ultrasound (HIFU) technology known as Focal One®. The non-invasive, radiation-free approach destroys cancerous tissue with pinpoint accuracy, significantly reducing the risk of side effects and preserving patient quality of life.
Standard treatments for localized prostate cancer include radical procedures like removing the entire prostate or radiating the whole gland, each of which carries a higher risk of life-altering side effects. The HIFU approach offers a more personalized approach for select candidates, allowing urologists to treat only the cancerous tissue instead of the entire organ.
The technology avoids damaging critical structures like the urinary sphincter, which controls urination, and the neurovascular bundles essential for erectile function. “Our goal is to attack the cancer without compromising the functions that are so important to a man’s daily life,” added Dr. Fam. “For patients, this means a significantly lower risk of incontinence and impotence.”
A convenient patient experience is a key benefit of the procedure, which is performed in a single session, enabling patients to typically go home the same day, and allowing for a quicker recovery time.
Physicians can now refer patients with localized prostate cancer for HIFU therapy at Jersey Shore University Medical Center. The treatment is also provided at Hackensack Meridian Hackensack University Medical Center.